These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 83080)
21. Identification of bullous pemphigoid, pemphigus, laminin, and anchoring fibril antigens in human fetal skin. Lane AT; Helm KF; Goldsmith LA J Invest Dermatol; 1985 Jan; 84(1):27-30. PubMed ID: 3880793 [TBL] [Abstract][Full Text] [Related]
22. Complement activation in pemphigus and bullous pemphigoid. Jordon RE J Invest Dermatol; 1976 Sep; 67(3):366-71. PubMed ID: 787432 [No Abstract] [Full Text] [Related]
23. Distribution of pemphigus and pemphigoid antigens, laminin, and type IV collagen in corneal epithelium. Cowen SJ; Anhalt GJ; Wicha MS; Sugar A; Labib RS; Diaz LA Invest Ophthalmol Vis Sci; 1981 Dec; 21(6):879-82. PubMed ID: 7031010 [TBL] [Abstract][Full Text] [Related]
24. Value of immunofluorescent techniques in studies of bullous disease. Maize JC; Provost TT Am J Dermatopathol; 1983 Feb; 5(1):67-72. PubMed ID: 6344686 [TBL] [Abstract][Full Text] [Related]
25. [Application of the biotin-avidin system to the study of autoimmune bullous diseases: immunofluorescence method using biotinylated-pemphigus and -pemphigoid antibodies and fluoresceinated avidin]. Muramatsu T; Sakamoto K; Ikeda S Nihon Hifuka Gakkai Zasshi; 1988 Sep; 98(10):977-80. PubMed ID: 3065537 [No Abstract] [Full Text] [Related]
26. Detection of autoantibodies in autoimmune bullous skin diseases: can we do better? Baum S; Zafrir Y; Barzilai A Isr Med Assoc J; 2014 Apr; 16(4):244-5. PubMed ID: 24834762 [No Abstract] [Full Text] [Related]
27. [Bullous pemphigoid with pemphigus type antibodies in vivo. 2 cases]. Bernard P; Catanzano G; Vignaud St Florent JD; Fayol J; Bonnetblanc JM Ann Dermatol Venereol; 1986; 113(8):671-6. PubMed ID: 3541760 [TBL] [Abstract][Full Text] [Related]
28. Human amnion membrane as a substrate for the detection of autoantibodies in pemphigus vulgaris and bullous pemphigoid. Sezin T; Avitan-Hersh E; Indelman M; Moscona R; Sabo E; Katz R; Pollack S; Bergman R Isr Med Assoc J; 2014 Apr; 16(4):217-23. PubMed ID: 24834757 [TBL] [Abstract][Full Text] [Related]
34. IgG subclasses of intercellular and basement membrane zone antibodies: the relationship to the capability of complement fixation. Yamada H; Hashimoto T; Nishikawa T J Invest Dermatol; 1989 Apr; 92(4):585-7. PubMed ID: 2649595 [TBL] [Abstract][Full Text] [Related]
35. Clinico-immunologic correlations in pemphigus and bullous pemphigoid. Fabbri P; Panconesi E Int J Dermatol; 1979 Sep; 18(7):565-70. PubMed ID: 387623 [TBL] [Abstract][Full Text] [Related]
36. Pemphigus and pemphigoid: dermatologic examples of type II immune reactivity. Sams WM Ann Allergy; 1976 Oct; 37(4):255-63. PubMed ID: 791025 [TBL] [Abstract][Full Text] [Related]
38. Pemphigus and pemphigoid. A review of the advances made since 1964. Lever WF J Am Acad Dermatol; 1979 Jul; 1(1):2-31. PubMed ID: 387823 [No Abstract] [Full Text] [Related]
39. Absence of anti-Ro and anti-La antibodies in pemphigus and pemphigoid sera. Ahmed AR Arch Dermatol Res; 1988; 280(2):127-8. PubMed ID: 3293539 [No Abstract] [Full Text] [Related]
40. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations. Lazarova Z; Yancey KB J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]